Home
Focus Areas
About Us
It's called the "pill penalty," and it's causing a lot of trouble in the medical world.
It's the result of a provision in the 1990 Inflation Reduction Act that requires Medicare to pay 10% of the cost of a new drug when it comes on the marketeven if that drug is made by a single company and costs no more than $10,000, the Wall Street Journal reports.
But when it comes to so-called " biologics," which include cancer drugs and rheumatoid arthritis drugs, Medicare only has to pay 10% of the cost when they're made by a single company and no more than $5,000 when they're made by multiple companies.
"The pill penalty is essential not only for ensuring equitable access to innovative treatments but also for safeguarding public health, particularly in the face of emerging health challenges such as antimicrobial resistance and infectious diseases like COVID-19," one doctor writes in an op-ed in the New York Times.
"Marginalized patients, including Black and Hispanic Americans disproportionately affected by certain diseases, rely on easy-to-take pills for effective treatment," he writes.
"The development of single-tablet regimens has been crucial in managing conditions like HIV/AIDS, highlighting the importance of small-molecule drugs in improving health outcomes
Selected Grant News Headlines
A customized collection of grant news from foundations and the federal government from around the Web.
Foundation: Community Foundation of Abilene
Big Country's CASA program seeks volunteers to support local foster children.Court Appointed Special Advocates (CASA) organization has expressed a dire need for volunteers in the Big Country.CASA...more
New NIH grant to explore impacts of PFAS on male reproductive health.Two-year, $95,178 grant is funded by the National Institute of Environmental Health Sciences of the NIH.Wayne State University is...more
The American Hospital Association (AHA) appreciates the opportunity to provide comment on the Centers for Medicare & Medicaid Services (CMS) and Assistant Secretary for Technology Policy/Office of...more
Lancaster expert warns against dangerous social media challenge risking brain injury.Lancaster University expert warns of high risk of acute brain trauma, catastrophic neck and spine injury, and the...more
Growth was largely concentrated in the non-beverages space, which saw a whopping 109.7% growth to KRW59.2bn (US$43.8m) In terms of product types, a total of 590 Sugar Zero products were reported in...more
A federal judge on Monday declared the Trump administration's move to cut hundreds of grants issued by the National Institutes of Health illegal.The judge accused the government of discrimination...more
Zijing Yang, Student Fellow, Stanford LLM 2025.Chinaa€™s national drug centralized procurement policy implemented since 2018 for off-patent drugs.The Medical Insurance Negotiation leverages...more
'Go Healthy with Taiwan' invites submissions from Australian health innovators - Biotech.'Go Healthy' with Taiwan is a joint initiative between Taiwan and Australia.It aims to promote healthy eating,...more
English has spent her career working at the intersection of farming and public health.Before joining the Walton Personal Philanthropy Group as a senior program officer, she was director of the...more
A clinical decision support system (CDSS) is a broad concept with many definitions that are used variably.CDSS includes a mix of evidence (content), analytics, workflow, devices, and software-based...more
Social Entrepreneurship
Spotlight
When it Comes to Social Enterprises, Failure is the Best Platform for Innovation
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.
